RAFAEL
PÉREZ GARCÍA
Investigador hasta 2018
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (7)
2023
-
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration
Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2254-2261
2021
-
Hemodialysis Centers Guide 2020
Nefrologia, Vol. 41, pp. 1-77
2017
-
Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study
American Journal of Nephrology, Vol. 46, Núm. 4, pp. 288-297
2016
-
Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk
Kidney International, Vol. 90, Núm. 6, pp. 1332-1341
2015
-
Cumulative iron dose and resistance to erythropoietin
Journal of Nephrology, Vol. 28, Núm. 5, pp. 603-613
2012
-
Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: Results from years 2009-2010
Nefrologia, Vol. 32, Núm. 6, pp. 743-753
2006
-
Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: A cross-sectional multicentre study
Nephrology Dialysis Transplantation, Vol. 21, Núm. 2, pp. 459-465